Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico

International Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 298-300

  Torres, Javier ^a   Pérez Pérez, Guillermo I ^b   Leal Herrera, Yelda ^a   Muñoz, Onofre ^a  

^a HOSPITAL DE PEDIATRÍA   (Mexico)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ANTIBODY BLOOD LEVEL; ARTICLE; CANCER MORTALITY; CANCER RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; RISK ASSESSMENT; SEROPREVALENCE; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; ANTIBODIES, BACTERIAL; FEMALE; GEOGRAPHY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MEXICO; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; STOMACH NEOPLASMS;

EID: 0032578692     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981029)78:3<298::AID-IJC6>3.0.CO;2-Q     Document Type: Article

References (20)

1. BLASER, M.J., PÉREZ-PÉREZ, G.I., KLEANTHOUS, H., COVER, T.L., PEEK, R.M., CHYOU, P.H., STEMMERMANN, G.N. and NOMURA, A., Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res., 55, 2111-2115 (1995).
2. BLASER, M.J., PÉREZ-PÉREZ, G.I., LINDENBAUM, J., SCHNEIDMAN, D., VAN DEVENTER, G., MARIN-SORENSEN, M. and WEINSTEIN, W.M., Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology, Rev. infec. Dis., 13 (Suppl. 8), S704-S708 (1991).
3. CAMORLINGA-PONCE, M., ESCOBAR-LUJAN, A., GONZÁLEZ-ORTIZ, B., MADRAZO-DE LA GARZA, A., PÉREZ-PÉREZ, G., MUÑOZ, O., DEHESA, M. and TORRES, J., Immune response to Helicohacter pylori antigens in infected children and adults. Gut. 39 (Suppl. 2), A39 (1996).
4. CENSINI, S., LANGE. C., XIANG, Z., CRABTREE, J.E., GHIARA, P., BORODOVSKY, M., RAPPUOLI, R. and COVACCI, A., cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. nat. Acad. SCi. (Wash.), 93, 14648-14653 (1996).
5. CHOW, W.H., BLASER, M.J., BLOT, W.J., GAMMON, M.D., VAUGHAM, T.L., RISCH, H.A., PÉREZ-PÉREZ, G.I. and FRAUMENI, J.F., H. pylori and CagA status in relation to risk of adenocarcinoma of esophagus and stomach by anatomic subsite. Gut, 41 (Suppl. 1), A33 (1997).
6. CORREA, P., Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res., 52, 6735-6740 (1996).
7. CRABTREE, J.E., TAYLOR, J., WYATT, J.I., HEATLEY, R.V., SHALLCROSS, T.M., TOMPKINS, D.S. and RATHBONE, B.J., Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet, 338, 332-335 (1993a).
8. CRABTREE, J.E., WYATT, J.I., SOBALA, G.M., MILLER, G., TOMPKINS, D.S., PRIMROSE, J.N, and MORGAN, A.G., Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut, 34, 1339-1343 (1993b).
9. KLAAMAS, K., HELD, M., WADSTRÖM, T., LIPPING, A. and KURTENKOV, O., IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int. J. Cancer, 67, 1-5 (1996).
10. KUIPERS, E.J., THIJS, J.C. and FESTEN, H.P.M., The prevalence of Helicobac ter pylori in peptic ulcer disease. Aliment. Pharmacol. Ther., 9 (Suppl. 2), 59-69 (1995).
11. MITCHELL, H.M., HAZELL, S.L., LI, Y.Y. and HU, P.J., Serological response to specific Helicobacier pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Amer. J. Gastroenterol., 91, 1785-1788 (1996).
12. NEALE, K.R. and LOGAN, R.P.H., The epidemiology and transmission of Helicobacter pylori infection in children. Aliment. Pharmacol. Ther., 9 (Suppl. 2), 77-84 (1995).
13. + Helicobacter pylori strains. Lab. Invest., 71, 760-770 (1995).
14. + proportion of Helicobacter pylori infections. Int. J. Cancer, 72, 453-456 (1997a).
15. PÉREZ-PÉREZ, G.I., GROVES, F., ZHANG, L., You, W.C., FRAUMENI, J.F. and BLASER, M.J., Relationship between CagA seroprevalence and gastric cancer rates in Chinese populations. Gut, 41 (Suppl. 1), A49 (1991b).
16. SONNENBERG, A., Temporal trend and geographical variations of peptic ulcer disease. Aliment. Pharmacol. Ther., 9 (Suppl. 2), 3-12 (1995).
17. TAPIA-CONYER, R., GUTIÉRREZ, G. and SEPÚLVEDA, J., Metodología de la encuesta nacional seroepidemiológica. Salud Pública Mex., 34, 124-135 (1992).
18. TORRES, J., LEAL-HERRERA, Y., CAMORLINGA-PONCE M., JIMÉNEZ-RAMÍREZ, C., GÓMEZ, A., MUÑOZ, O., TAPIA-CONYER, R., FERNÁNDEZ-QUINTANILLA, G. and PÉREZ-PÉREZ, G., Seroprevalence to Helicobacter pylori infection in Mexico. Gut, 39 (Suppl. 2), A83 (1996).
19. WEBB, P.M., FORMAN, D., NEWELL, D., COVACCI, A., CRABTREE, J.E. and EUROGAST STUDY GROUP, An international association between prevalence of infection with CagA positive strains of H. pylori and mortality from gastric cancer. Gut, 39, A1 (1996).
20. ZHANG, L. and 15 OTHERS, Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol. Biomarkers Prevent., 5, 627-630 (1996).